SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The total revenue hovered 499.14% to Rs. 3367.49 millions for the December 2024 quarter as against Rs. 562.05 millions during the corresponding quarter last year.The Net Loss for the quarter ended December 2024 is Rs. -730.23 millions as compared to Net Loss of Rs. -1606.24 millions of corresponding quarter ended December 2023 Operating profit Margin for the quarter ended December 2024 improved to 1053.93% as compared to -92.32% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202412 202312 % Var
Sales 3367.49 562.05 499.14 3367.49 562.05 499.14 3367.49 562.05 499.14
Other Income 50.14 11.07 352.94 50.14 11.07 352.94 50.14 11.07 352.94
PBIDT 1053.93 -92.32 -1241.61 1053.93 -92.32 -1241.61 1053.93 -92.32 -1241.61
Interest 439.17 260.06 68.87 439.17 260.06 68.87 439.17 260.06 68.87
PBDT -390.47 -1410.99 -72.33 -390.47 -1410.99 -72.33 -390.47 -1410.99 -72.33
Depreciation 339.76 195.25 74.01 339.76 195.25 74.01 339.76 195.25 74.01
PBT -730.23 -1606.24 -54.54 -730.23 -1606.24 -54.54 -730.23 -1606.24 -54.54
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -730.23 -1606.24 -54.54 -730.23 -1606.24 -54.54 -730.23 -1606.24 -54.54
Equity 114.43 40.10 185.36 114.43 40.10 185.36 114.43 40.10 185.36
PBIDTM(%) 31.30 -16.43 -290.54 31.30 -16.43 -290.54 31.30 -16.43 -290.54

Onesource Specialty Share Price

1540.35 34.40 (2.28%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×